Inventor
CHANOCK ROBERT M
US31 patents
⚠️ This page may combine multiple inventors who share the name “CHANOCK ROBERT M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
17 patentsUS5922326AJul 13, 1999
Attenuated respiratory syncytial virus vaccine compositions
US HEALTH109 citations99
US6184024B1Feb 6, 2001
Chimeric and/or growth-restricted flaviviruses
US HEALTH140 citations96
US6676936B1Jan 13, 2004
Chimeric and/or growth-restricted flaviviruses
US HEALTH25 citations91
US5882651AMar 16, 1999
Attenuated respiratory syncytial virus vaccine compositions
US HEALTH19 citations90
US4571385AFeb 18, 1986
Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors
US HEALTH39 citations89
US4927628AMay 22, 1990
Vaccine against rotavirus diseases and method of preparing same
US HEALTH24 citations87
US7150984B2Dec 19, 2006
Attenuated human rotavirus vaccine
US HEALTH13 citations83
US4751080AJun 14, 1988
Vaccine against rotavirus diseases
US HEALTH21 citations80
US4704275ANov 3, 1987
Vaccine against rotavirus diseases
US HEALTH24 citations80
US4341870AJul 27, 1982
Cultivatable human rotavirus type 2
US HEALTH20 citations75
US10058602B2Aug 28, 2018
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
US HEALTH3 citations72
US6284254B1Sep 4, 2001
Immunogenic compositions comprising cold-adapted attenuated respiratory syncytial virus mutants
US HEALTH5 citations71
US11400150B2Aug 2, 2022
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
US HEALTH0 citations62
US10869920B2Dec 22, 2020
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
US HEALTH0 citations51
US10456461B2Oct 29, 2019
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
US HEALTH0 citations51
US7932074B1Apr 26, 2011
Multivalent human-bovine rotavirus vaccine
US HEALTH0 citations51
US6794174B2Sep 21, 2004
Full-length infectious cDNA clones of tick borne flavivirus
US HEALTH0 citations49
DYNCORP
4 patentsUS5911998AJun 15, 1999
Method of producing a virus vaccine from an African green monkey kidney cell line
DYNCORP14 citations79
US6117667ASep 12, 2000
Method for producing an adapted virus population from an African green monkey kidney cell line
DYNCORP1 citations60
US6025182AFeb 15, 2000
Method for producing a virus from an african green monkey kidney cell line
DYNCORP2 citations60
US5646033AJul 8, 1997
African green monkey kidney cell lines useful for maintaining viruses and for preparation of viral vaccines
DYNCORP1 citations60
SCRIPPS RESEARCH INST
3 patentsUS5762905AJun 9, 1998
Human neutralizing monoclonal antibodies to respiratory syncytial virus
SCRIPPS RESEARCH INST112 citations95
US6685942B1Feb 3, 2004
Human neutralizing monoclonal antibodies to respiratory syncytial virus
SCRIPPS RESEARCH INST64 citations94
US7364737B2Apr 29, 2008
Human neutralizing monoclonal antibodies to respiratory syncytial virus
SCRIPPS RESEARCH INST18 citations92
ST JUDE CHILDRENS RES HOSPITAL
2 patentsUS4552758ANov 12, 1985
Human use of avian-human reassortants as vaccines for influenza A virus
ST JUDE CHILDRENS RES HOSPITAL73 citations94
US4552757ANov 12, 1985
Use in an animal host and precursors for vaccines utilizing avian-human reassortants to combat influenza A virus
ST JUDE CHILDRENS RES HOSPITAL5 citations61